Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study
- 14 November 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Osteoporosis International
- Vol. 24 (1), 271-277
- https://doi.org/10.1007/s00198-012-2213-5
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- The association of bone density and calcified atherosclerosis is stronger in women without dyslipidemia: The multi-ethnic study of atherosclerosisJournal of Bone and Mineral Research, 2011
- (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosisArthritis Research & Therapy, 2011
- Zoledronic Acid Reduces Bone Loss and Tumor Growth in an Orthotopic Xenograft Model of Osteolytic Oral Squamous Cell CarcinomaCancer Research, 2010
- Relation of Bisphosphonate Therapies and Risk of Developing Atrial FibrillationThe American Journal of Cardiology, 2009
- Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysisVascular Health and Risk Management, 2009
- Association of Coronary Artery and Aortic Calcium With Lumbar Bone Density: The MESA Abdominal Aortic Calcium StudyAmerican Journal of Epidemiology, 2008
- Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control studyBMJ, 2008
- Urbanicity and Methods of Suicide: A Nationwide Population-based StudyJournal of Urban Health, 2007
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureThe New England Journal of Medicine, 2007
- Effect of Etidronic Acid on Arterial Calcification in Dialysis PatientsClinical Drug Investigation, 2006